BackSangamo Therapeutics Overview

Sangamo Therapeutics Current Assets

Sangamo Therapeutics's current assets is $37M.

Get informed when a big investor buys or sells

+ Follow
Current Assets
$37.11M
1.28% YoYΔ $-483000.00 vs prior year quarter

Peer trimmed avg / median

Loading

Sangamo Therapeutics Current Assets History

Loading

Sangamo Therapeutics vs. peers: Current Assets Comparison

Loading

Sangamo Therapeutics Current Assets Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Sangamo Therapeutics (SGMO) FAQ

As of the most recent data (March 2026), SGMO shows a current assets of $37M. That compares with $38M in the prior-year period — down 1.3% year over year. Scroll down for historical charts and peer comparison views.

Compared with the year-ago period, SGMO's current assets is now $37M (was $38M) — a 1.3% year-over-year decrease. Pairing that YoY change with peer averages gives a clearer picture of whether Sangamo Therapeutics is outperforming or lagging.

Tracking SGMO's current assets over time shows whether Sangamo Therapeutics is scaling, shrinking, or reshaping that part of the business. The current reading is $37M That compares with $38M in the prior-year period — down 1.3% year over year. Multi-quarter patterns matter more than any single print, which is why this page emphasizes history and peer comparison charts.

Besides this current assets page, Stockcircle has Sangamo Therapeutics's full stock overview, other financial metrics, insider and congress trade tabs, and tools to follow the stock. Together they help you connect current assets (currently $37M) with ownership activity and broader fundamentals.

Sangamo Therapeutics's current assets is $37M; compare it with other Healthcare names on the peer chart. Typical ranges vary by sub-industry, so always sanity-check against the closest competitors, not just the whole sector bucket.